Abstract

Bladder tumors are the second most common genitourinary tumor after prostate tumors. In addition, it is known that urothelial carcinoma is the most common histological form. It accounts for 90% of all bladder tumors. Primary adenocarcinoma of the bladder is a rare malignant tumor. Consequently, an extension assessment is required to exclude any secondary tumor extension. Clinical presentations are not specific and remain dominated by hematuria. His prognosis is poor, and his management is essentially surgical by performing a total cystectomy associated with an extensive lymph node dissection due to radio-chemo-resistance. <i>Background</i> The authors report the first case of bladder adenocarcinoma. It was a 65-year-old patient who consulted at university hospital of Brazzaville for a dysuria type of slow start-up, weak jet and a total hematuria, evolving for 1 month before his consultation. The anamnesis noted a notion of smoking intoxication of a package year for 10 years. The histological diagnosis was made on basis of the results of the analysis of the trans urethral resection parts of the bladder tumor. In order to rule out any secondary extension, a radiological assessment made of computerized tomography (CT) had been carried out. The evolution was quickly fatal. <i>Conclusion</i> Bladder adenocarcinoma is a Clinical Anatomy Variant entity whose Its aggressive nature makes the prognosis poor, hence the interest in making the diagnosis early.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call